|
6/2020
vol. 58
abstract:
Original paper
Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
1.
Azienda Sanitaria Locale Napoli 3 sud, Internal and Geriatric Medicine Department, Internal and Geriatric Medicine Department, Rheumatologic Outpatient Clinic Hospital “Mariano Lauro”, Sant’Agnello, Italy
2.
National Institute of Mental Health "Honorio Delgado – Hideyo Noguchi", Lima, Perú
3.
Department of Rheumatology, Internal Medicine, Geriatrics, and Clinical Immunology, Pomeranian Medical University, Szczecin, Poland
4.
Library and Knowldege Services, Central and North West London NHS Foundation Trust, London, United Kingdom
5.
Azienda Sanitaria Provinciale Catanzaro, Internal and Geriatric Medicine Department, Fragility Outpatient Clinic, Catanzaro, Italy
6.
Azienda Sanitaria Locale Napoli 3 sud, Internal Medicine Department, Rheumatologic Outpatient Clinic, Health District no. 58, Gragnano, Naples, Italy
7.
Department of Old Age Psychiatry, Central and North West London NHS Foundation Trust, London, United Kingdom
Reumatologia 2020; 58, 6: 381–389
Online publish date: 2020/12/23
Introduction
In 1979, Bird et al. proposed depression as a diagnostic criterion for polymyalgia rheumatica (PMR). More recently, the significance of depression in PMR patients has been re-proposed, , and some researchers have suggested that PMR may increase the risk of depression. The aim of our article is to evaluate the relationship between PMR and depression.
Material and methods
Systematic literature searches were performed on 19th and 20th May 2020 based on Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. The search was restricted to all studies and case reports with English abstract, published in any language, since 1979 (when depression was first proposed as a diagnostic criterion for PMR) describing the association of PMR with depression. Exclusion criteria were as follows: reviews, conference abstracts, comments, non-original articles; and articles discussing giant cell arteritis (GCA) and PMR when data and observations for the two conditions were not clearly subdivided.
Results
The initial search yielded 812 papers, of which 115 duplicates were removed. A total of 697 articles had a first screening and 506 were excluded based on title and abstract reviews; 117 articles underwent full-length scrutiny, and 99 full-text articles were excluded because they did not meet the inclusion and exclusion criteria (reviews and comments = 58; articles with outcome of interest not reported = 34; low-quality articles = 7). At least, 18 articles were included in this review.
Conclusions
The review did not find any studies that clarified the prevalence rates of depression in patients with PMR. Furthermore, the studies reviewed did not offer any clarity as to whether patients suffered from just depressive symptoms or clinical depression, and that accepted diagnostic criteria for depression had not been employed, indicating that a robust method for diagnosing depression had not been employed. Collaboration of different professionals should be improved through shared guidelines.
keywords:
polymyalgia rheumatica, depression, depressive symptoms, systematic review
|
|
